Vascular access
A vascular access procedure inserts a flexible, sterile plastic tube called a catheter into a blood vessel to allow blood to be drawn from or medication to be delivered to a patient’s bloodstream over an extended period.
There are three access types for hemodialysis: arteriovenous (AV) fistula, AV graft and central venous catheter. Each access is created surgically. There are a limited number of places on the body where an access can be placed—the arms, legs, neck or chest. The fistula and graft are considered to be permanent accesses because they are placed under the skin with a plan to use them for many years.
- the Arterio Venous (AV) fistula
- the Arterio Venous (AV) graft
- the central venous catheter or internal port devices (LifeSite®)
Each access is created surgically. There are a limited number of places on the body where an access can be placed—the arms, legs, neck or chest.
The fistula and graft are considered to be permanent accesses because they are placed under the skin with a plan to use them for many years. When patients find out they are in the advanced stages of chronic kidney disease and will be starting dialysis in the future, their nephrologist will advise them to get a fistula or graft. Having the access in place well before beginning dialysis will give this lifeline time to "mature," so it can be ready to use.
When patients suddenly discover they have kidney failure, a catheter may be placed to allow for immediate dialysis treatment. The catheter will be used until a fistula or graft has time to mature. A catheter can also be used on a permanent basis, if the patient is unable to have a fistula or graft—but a catheter is always a last resort.
AV Fistula
An AV fistula is created by directly connecting a person’s artery and vein—usually in the arm. This procedure may be performed as an outpatient operation using a local anesthetic. As blood flows to the vein from the newly connected artery, the vein grows bigger and stronger. The patient is taught to do exercises—such as squeezing a rubber ball—to help the fistula strengthen and mature to get it ready for use. This takes anywhere from six weeks to four months or more. Once the fistula has matured, it can provide good blood flow for many years of hemodialysis.
Kidney and hemodialysis experts, including the National Kidney Foundation (NKF), Centers for Medicare and Medicaid Services (CMS), the American Association of Kidney Patients (AAKD) and others consider the fistula the "gold standard" access choice. Research studies have proven patients with a fistula have the fewest complications, such as infection or clotting, compared to all other access choices.
Currently, an access improvement initiative known as "Fistula First" is being sponsored by CMS throughout the United States to support an increase in the use of fistulas for hemodialysis patients.
The fistula is considered the "gold standard" access because it:
- has a lower risk of infections than other access types
- has a lower risk of forming clots than other access types
- performs better than other accesses
- allows for greater blood flow
- lasts longer than the other access types
- can last many years, even decades, when well-cared for
Some issues people may have with fistulas include:
- the appearance of bulging veins at the access site
- taking several months for a new one to mature
- not maturing at all in some cases
Not everyone may be able to have a fistula due to weak arteries, veins or other medical conditions; it is best to discuss your access options with your doctor, but ask for a fistula first.
AV Graft
The AV graft is similar to a fistula, in that it is also an under the skin connection of an artery and vein, except that with a graft, a man-made tubing connects the artery and vein. The soft, plastic-like tube is about one-half inch in diameter and is made from a type of Teflon® or Gore-Tex® material. Transplanted animal or human vessels may also be used as grafts to connect an artery and vein. Grafts are usually placed in the arm, but can also be placed in the thigh.
Grafts do not require as much time to mature as fistulas, because the graft does not need time to enlarge before using. In most cases a graft can be used about two to six weeks after placement. Because grafts are created from materials outside of the body, they tend to have more problems than fistulas due to clotting and infections. Grafts may not last as long as a fistula and could need to be repaired or replaced each year.
Caring for a fistula or graft
Taking good care of your fistula or graft will help keep it working properly. There are a few things you can do to help prevent infections, clotting and damage to your access.
Cleanliness is important to keep out infections
Keep your access area clean and free of any trauma. Look for signs of infection including: pain, tenderness, swelling or redness around your access area. Also, be aware of any fever and flu-like symptoms. If you do get an infection and catch it early, it can usually be treated with antibiotics.
Your dialysis care team will teach you how to carefully wash your access arm before each dialysis treatment. Make sure to wash thoroughly and be sure the care team member specially prepares your access site to prevent infection.
Unrestricted blood flow helps lower the risk of clotting
Protect your access from any restriction or trauma by:
- avoiding tight clothes, jewelry or anything that may put pressure on your access
- not sleeping on top of or resting on your access area
- refraining from carrying purses, bags or heavy items across your access area
- always requesting that blood be drawn from your non-access arm
- always requesting that blood pressure be taken from your non-access arm
Learn the feel of the "thrill" or vibration of blood going through your access and check it several times a day. Call your dialysis care team immediately if the flow stops or changes. This could mean a blood clot. With quick action, many clots can be dissolved or removed.
Learn to listen with a stethoscope to the sound (called "bruit") of blood flowing ("whooshing") through your access. If the sound of the bruit changes to a higher pitch, like a whistle, it could be an indication that blood vessels are narrowing (call stenosis), which may slow or stop blood flow through your access. If you do not hear the bruit at all, or only your pulse, you may have a blood clot in your access. Call your dialysis care team if you notice any change in your access.
Good needle sticks (cannulation) can help keep your access working well
To prevent tearing or damage to your access, it’s recommended that you pay attention to the needle stick locations when you’re being put on dialysis. The arterial and venous needle tips should be at least two inches apart from each other, as well as away from access surgical scars. The new needle stick sites should be at least one-fourth inch from the sites used the time before. Allow about two weeks for healing of previous sites to help maintain the health of the access.
Many people are nervous about having needles placed; however, there are numbing creams that can be used to reduce the pain and fear of needle sticks. Talk to your nephrologist and dialysis care team about ways to decrease pain and to calm anxiety.
Have you ever considered learning how to stick your own access (called self cannulation)? Many patients find they prefer having control of the needle stick process. When you self cannulate, you can control and participate in this part of your vascular access care and treatment. If you’d like to learn how to self-cannulate, ask a dialysis team member. You’ll receive education and training.
After dialysis treatment your needles will be removed and you will need to apply pressure with sterile gauze over your needle sites to stop the bleeding. Your dialysis team will provide you with clean gloves and teach you the proper procedures to stop bleeding as well as prevent infection.
Catheters and Internal Port Devices (LifeSite®)
A catheter is a narrow tube that is placed into a large central vein, usually in the patient’s neck, chest or groin. Placement of the catheter usually takes less than a half hour. Usually, two tubes extend out of the body from the catheter: one allows blood out of the body (arterial port) and one allows blood back into the body (venous port).
Internal port devices are special access systems, which are placed under the skin and connected to very large venous catheters to provide access to remove blood out of the body for cleaning and then back into the body.
Catheters and internal port devices can be used for dialysis immediately after placement. A catheter or internal port device may be used when one must begin dialysis before a fistula or graft has time to mature.
Some patients use permanent catheters, however, kidney and hemodialysis experts, including the National Kidney Foundation (NKF), Centers for Medicare and Medicaid Services (CMS), the American Association of Kidney Patients (AAKD) and others do not recommend catheters and internal port devices for long-term hemodialysis. Concerns with catheters or internal port devices include:
- a greater likelihood to become infected, clotted or fail
- a slower blood flow so dialysis may not clean the blood as thoroughly as with a fistula or graft
- inferior access for long-term hemodialysis
Caring for a catheter and Internal Port Devices (LifeSite®)
Catheters and internal port devices will require care to keep them protected, free of infections and working well.
Cleanliness helps prevent infections
It is very important to always keep your catheter exit site clean and dry. This may mean you cannot swim, take showers or soaking baths. You will need to carefully wash without getting your unhealed catheter exit site wet. Your physician may allow you to shower once your catheter exit site is well healed.
Your dialysis care team will teach you how to protect your catheter or internal port device when it is not being used for dialysis. You will be taught the importance of making sure your catheter clamps are clamped and end-caps are on securely when you’re not dialyzing. These will help decrease your risk of infection and avoid air from getting into your catheter. You will also be taught to check regularly for signs of infection such as redness, swelling, pain, pus or fever. Call your dialysis care team right away if you think you may have an infection.
Special precautions such as wearing a nose and mouth covering masks whenever your catheter is being accessed will help prevent any microbes from your nose or mouth from contaminating the catheter or exit site. Your dialysis care team members will also wash their hands and wear clean gloves when caring for your access.
Protect your catheter
Because your catheter exits and extends from your body, you’ll need to be careful not to pull on or tug it, or the protective dressing. Take care to be gentle around your catheter when getting dressed and undressed or removing a blanket or covering. Always keep sharp instruments, such as scissors, away from your catheter.
- Arteriovenous fistula recirculation in hemodialysis
- Arteriovenous graft creation for hemodialysis and its complications
- Central vein stenosis associated with hemodialysis access
- Clinical monitoring and surveillance of the mature hemodialysis arteriovenous fistula
- Creating an arteriovenous fistula for hemodialysis
- Endovascular intervention for the treatment of stenosis in the arteriovenous access
- Examination of the mature hemodialysis arteriovenous fistula
- Failure of the mature hemodialysis arteriovenous fistula
- Heart failure and hemodialysis arteriovenous fistulae
- Hemodialysis anticoagulation
- Hemodialysis arteriovenous graft dysfunction and failure
- Maturation and evaluation of the newly created hemodialysis arteriovenous fistula
- Monitoring and surveillance of hemodialysis arteriovenous grafts to prevent thrombosis
- Nonthrombotic complications of arteriovenous hemodialysis access
- Overview of chronic hemodialysis vascular access
- Overview of hemodialysis arteriovenous fistula maintenance and thrombosis prevention
- Overview of hemodialysis arteriovenous graft maintenance and thrombosis prevention
- Patient evaluation and vascular mapping prior to placement of hemodialysis arteriovenous access
- Physical examination of the arteriovenous graft
- Primary failure of the hemodialysis arteriovenous fistula
- Secondary hemodialysis arteriovenous fistula
- Techniques for angioplasty of the arteriovenous hemodialysis access
- Thrombosis associated with chronic hemodialysis vascular catheters
Related Conference of Vascular access
9th Global Summit onNephrology, Urology and Kidney Transplantation
13th European Congress on Nephrology, Internal Medicine and Kidney Diseases
7th International Conference on Clinical Immunology, Neuropharmacology and Drug Development
Vascular access Conference Speakers
Recommended Sessions
- Acute Renal Failure and Dialysis
- Anemia and Chronic Renal Failure
- Cardiac Disease and Hypertension
- Complications during Dialysis
- Dialysis Adequacy
- Dialysis Modalities
- Endocrine Dysfunction
- Hemodialysis
- Infection and Dialysis
- Intoxications
- Nutrition
- Other
- Peritoneal Dialysis
- Slow Continuous Therapies
- Vascular access
Related Journals
Are you interested in
- Advanced Imaging Techniques in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Advanced Urological Imaging - NEPHRO MEET 2025 (Singapore)
- Advances in Immuno-Oncology for CNS Tumors - Neuropharmacology 2025 (Italy)
- Advances in Kidney Transplantation - Nephrologists 2025 (France)
- AI-Driven Drug Discovery in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Artificial Intelligence and Machine Learning in Renal Diagnostics - EURO NEPHROLOGY 2025 (Italy)
- Artificial Intelligence in Nephrology - NEPHRO MEET 2025 (Singapore)
- Autoimmunity and Neuropharmacology: New Insights - Neuropharmacology 2025 (Italy)
- Biomarkers in Nephrology - NEPHRO MEET 2025 (Singapore)
- Biomarkers in Neuroimmune and Neuroinfectious Diseases - Neuropharmacology 2025 (Italy)
- Biomarkers of Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Blood-Brain Barrier: Challenges and Solutions - Neuropharmacology 2025 (Italy)
- Cardiorenal Syndrome - Euro Nephrology Summit 2025 (France)
- Cardiovascular Impact of Kidney Disease - Kidney Care 2025 (UK)
- Cardiovascular Impacts of Kidney Diseases - World Nephrology 2025 (Netherlands)
- Cardiovascular Risks in CKD - NEPHRO MEET 2025 (Singapore)
- Cell-Based Therapies in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Challenges in Paediatric Nephrology - Nephrologists 2025 (France)
- Chronic Kidney Disease - NEPHRO MEET 2025 (Singapore)
- Chronic Kidney Disease (CKD) - Kidney Care 2025 (UK)
- Chronic Kidney Disease and Diabetes - Nephrologists 2025 (France)
- Clinical Nephrology - Euro Nephrology Summit 2025 (France)
- Clinical Nephrology - World Nephrology 2025 (Netherlands)
- Clinical Trails in Kidney Therapy - Nephrologists 2025 (France)
- Clinical Trials in Neuroimmunology - Neuropharmacology 2025 (Italy)
- CRISPR Innovations for Kidney Disorders - EURO NEPHROLOGY 2025 (Italy)
- Diabetes and CKD - NEPHRO MEET 2025 (Singapore)
- Diabetic Nephropathy - Euro Nephrology Summit 2025 (France)
- Diabetic Nephropathy - Kidney Care 2025 (UK)
- Diagnostic, Imaging and Radiation Techniques - Euro Nephrology Summit 2025 (France)
- Diagnostic, Imaging and Radiation techniques - World Nephrology 2025 (Netherlands)
- Dialysis - Kidney Care 2025 (UK)
- Dialysis Innovations - NEPHRO MEET 2025 (Singapore)
- Diet for Kidney Health - Euro Nephrology Summit 2025 (France)
- Diet for Kidney Health - World Nephrology 2025 (Netherlands)
- Digital Health Innovations and Biomarker Development - EURO NEPHROLOGY 2025 (Italy)
- Drugs and Medication for Kidney Disease - World Nephrology 2025 (Netherlands)
- Drugs for Kidney Diseases - Kidney Care 2025 (UK)
- Drugs used in the treatment of Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Emerging Biomarkers in Nephrology - Nephrologists 2025 (France)
- Emerging Neuroprotective Agents - Neuropharmacology 2025 (Italy)
- Emerging Technologies and Diagnostics - World Nephrology 2025 (Netherlands)
- Emerging Therapies for Polycystic Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Environmental Risk Factors and Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Epigenetic Modulation in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Ethical and Regulatory Considerations in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Ethics and Policy in Renal Medicine - EURO NEPHROLOGY 2025 (Italy)
- Ethics in Kidney Donation and Transplantation - Nephrologists 2025 (France)
- Ethics in Kidney Transplantation - EURO NEPHROLOGY 2025 (Italy)
- Fluid and Electrolyte Disorders in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Gene Therapy and CRISPR in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Genetics of Kidney Disease - Nephrologists 2025 (France)
- Geriatric Nephrology and Aging Populations - EURO NEPHROLOGY 2025 (Italy)
- Global Perspectives in Nephrology and Urology - World Nephrology 2025 (Netherlands)
- Global Perspectives on kidney Health - Nephrologists 2025 (France)
- Glomerular Disease - Euro Nephrology Summit 2025 (France)
- Glomerular Disease - World Nephrology 2025 (Netherlands)
- Glomerular Disease - NEPHRO MEET 2025 (Singapore)
- Hereditary Kidney Disorders - Euro Nephrology Summit 2025 (France)
- Hydronephrosis - World Nephrology 2025 (Netherlands)
- Hypertension - Kidney Care 2025 (UK)
- Hypertension and Nephrology - NEPHRO MEET 2025 (Singapore)
- Hypertension associated with Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Immunomodulation and Targeted Therapies for Glomerular Diseases - EURO NEPHROLOGY 2025 (Italy)
- Immunomodulation in Stroke and Traumatic Brain Injury - Neuropharmacology 2025 (Italy)
- Innovations in Dialysis Techniques - Nephrologists 2025 (France)
- Innovations in Home-Based Renal Therapy: Smart Dialysis Devices - EURO NEPHROLOGY 2025 (Italy)
- Innovative Approaches to Stone Disease - Nephrologists 2025 (France)
- Integrating care for Kidney Failure - Nephrologists 2025 (France)
- Kidney and Bladder Cancer - Kidney Care 2025 (UK)
- Kidney and Bladder Stones - World Nephrology 2025 (Netherlands)
- Kidney Disease in Aging Population - Nephrologists 2025 (France)
- Kidney Health and Nutrition - Nephrologists 2025 (France)
- Kidney Stone Management - NEPHRO MEET 2025 (Singapore)
- Kidney Stones - Euro Nephrology Summit 2025 (France)
- Kidney Stones - Kidney Care 2025 (UK)
- Kidney Transplant - Kidney Care 2025 (UK)
- Kidney Transplant Immunology - NEPHRO MEET 2025 (Singapore)
- Kidney Transplantation - Euro Nephrology Summit 2025 (France)
- Kidney Transplantation - World Nephrology 2025 (Netherlands)
- Kidney-on-a-Chip Technology - EURO NEPHROLOGY 2025 (Italy)
- Managing Chronic Kidney Disease - Nephrologists 2025 (France)
- Microbiome-Targeted Therapies in Neurology - Neuropharmacology 2025 (Italy)
- Mineral and Bone Disorder in CKD - Kidney Care 2025 (UK)
- Minimally Invasive Surgery - NEPHRO MEET 2025 (Singapore)
- Minimally Invasive Urological surgery - Nephrologists 2025 (France)
- Molecular Mechanisms of Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Nanomedicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Nanotechnology in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Nephrology - Euro Nephrology Summit 2025 (France)
- Nephrology Advances - World Nephrology 2025 (Netherlands)
- Nephrology Nursing - Kidney Care 2025 (UK)
- Nephrotic Syndrome - Euro Nephrology Summit 2025 (France)
- Nephrotic Syndrome - World Nephrology 2025 (Netherlands)
- Neuro-urology - World Nephrology 2025 (Netherlands)
- Neuroimmune Crosstalk in Metabolic Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Interactions in Psychiatric Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Pathways in Pain Management - Neuropharmacology 2025 (Italy)
- Neuroinflammation: Mechanisms and Therapeutic Strategies - Neuropharmacology 2025 (Italy)
- Neuropharmacological Interventions in Neurodegenerative Disorders - Neuropharmacology 2025 (Italy)
- Neurotoxicology and Immunotoxicology - Neuropharmacology 2025 (Italy)
- Next-Generation Immunotherapies in Neurological Disorders - Neuropharmacology 2025 (Italy)
- Novel Drug Delivery Systems for Neuroimmune Agents - Neuropharmacology 2025 (Italy)
- Nutrition and Kidney Health - NEPHRO MEET 2025 (Singapore)
- Nutritional Genomics and Personalized Renal Dietetics - EURO NEPHROLOGY 2025 (Italy)
- Patient-Centered Care - World Nephrology 2025 (Netherlands)
- Patient-Centric Kidney Care - Nephrologists 2025 (France)
- Pediatric Nephrology - Euro Nephrology Summit 2025 (France)
- Pediatric Nephrology - NEPHRO MEET 2025 (Singapore)
- Pediatric Nephrology and Developmental Disorders - EURO NEPHROLOGY 2025 (Italy)
- Pediatric Nephrology and Urology - World Nephrology 2025 (Netherlands)
- Pediatric Neuroimmunology: Challenges and Innovations - Neuropharmacology 2025 (Italy)
- Pediatrics and Geriatric Nephrology - Kidney Care 2025 (UK)
- Personalized Kidney Care - NEPHRO MEET 2025 (Singapore)
- Personalized Medicine in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Pharmacogenomics and Personalized Medicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Pharmacogenomics in Renal Drug Response - EURO NEPHROLOGY 2025 (Italy)
- Post-Transplant Complications - NEPHRO MEET 2025 (Singapore)
- Precision Neuropharmacology: From Bench to Bedside - Neuropharmacology 2025 (Italy)
- Preventing Acute Kidney Injury - Nephrologists 2025 (France)
- Psychosocial aspects of Kidney Disease - Nephrologists 2025 (France)
- Regenerative Medicine and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Regenerative Medicine in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Renal Disease Diagnosis and Care - World Nephrology 2025 (Netherlands)
- Renal Pathology and Immunology - Kidney Care 2025 (UK)
- Renal Pathology-Immunology - World Nephrology 2025 (Netherlands)
- Renal Replacement Therapy - NEPHRO MEET 2025 (Singapore)
- Role of Pharmacotherapy in Nephrology - Nephrologists 2025 (France)
- Sexual Health in Urology - NEPHRO MEET 2025 (Singapore)
- Sexual Health in Urology - Kidney Care 2025 (UK)
- Sophisticated Imaging: 3D Mapping and Evaluation - EURO NEPHROLOGY 2025 (Italy)
- Stages of Kidney Diseases - Euro Nephrology Summit 2025 (France)
- Stem Cell and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Stem cells in Renal Disorders - Euro Nephrology Summit 2025 (France)
- Stem Cells in Renal Disorders - Kidney Care 2025 (UK)
- Surgery for Renal Disease - Kidney Care 2025 (UK)
- Technological Advancements in Nephrology - Euro Nephrology Summit 2025 (France)
- Telehealth in Urology - Nephrologists 2025 (France)
- The Neuroimmune Interface in Autoimmune Diseases - Neuropharmacology 2025 (Italy)
- The Role of AI in Nephrology - Nephrologists 2025 (France)
- Therapeutic Strategies - World Nephrology 2025 (Netherlands)
- Transplant Pharmacology - NEPHRO MEET 2025 (Singapore)
- Understanding Glomerular Diseases - Nephrologists 2025 (France)
- Urological Emergencies - NEPHRO MEET 2025 (Singapore)
- Urological Emergencies: Quick Response - Nephrologists 2025 (France)
- Urological Oncology - NEPHRO MEET 2025 (Singapore)
- Urological Oncology: Current Trends - Nephrologists 2025 (France)
- Urological Reconstruction - NEPHRO MEET 2025 (Singapore)
- Urology / Urinary Tract Infections - Kidney Care 2025 (UK)
- Urology and Sexual Health - Nephrologists 2025 (France)
- Urology Innovations - World Nephrology 2025 (Netherlands)
- Viral Infections and Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Women Health and Pregnancy - Kidney Care 2025 (UK)